It would thus be interesting to see if similar JAK2-mediated EZH2 degradation exists in NKTCL or that EZH2 switch to non-canonical function can be mediated by JAK1/2 as well. The gene discussed is JAK1; the disease is extranodal nasal NK/T cell lymphoma.